Medtronic Touts New Products, Advantages Of TAVR In Post-CABG Patients
This article was originally published in The Gray Sheet
Executive Summary
Medtronic launched new sizes of its repositionable transcatheter aortic valve replacement system. It also recently reported data for its first-generation CoreValve showing a benefit in high risk patients who had previously undergone coronary artery bypass surgery.